Singapore markets open in 4 hours 47 minutes
Straits Times Index
3,289.42 -23.93 (-0.72%) S&P 500
5,308.15 +61.47 (+1.17%) Dow
39,908.00 +349.89 (+0.88%) Nasdaq
16,742.39 +231.21 (+1.40%) Bitcoin USD
65,874.45 +4,294.46 (+6.97%) CMC Crypto 200
1,390.86 +122.92 (+9.69%)
Sedana Medical AB (7D2A.MU)
Munich - Munich Delayed price. Currency in EUR
Add to watchlist
At close: 08:10AM CEST
| Previous close | 1.8580 |
| Open | 1.9760 |
| Bid | 1.9980 x N/A |
| Ask | 2.0250 x N/A |
| Day's range | 1.9760 - 1.9760 |
| 52-week range | 1.2180 - 2.8640 |
| Volume | |
| Avg. volume | 6 |
| Market cap | N/A |
| Beta (5Y monthly) | N/A |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | 23 Jul 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
PR NewswireSedana Medical completes patient recruitment for INSPiRE-ICU 1 clinical trial in the US
Sedana Medical AB (publ) announces that all 235 randomized patients have been recruited for its INSPiRE-ICU 1 phase III clinical trial in the United States. Concurrently, the identical INSPiRE-ICU 2 trial is nearing completion, with 23 of 235 randomized patients remaining. The company anticipates topline results from both trials in the second half of 2024, with a planned New Drug Application (NDA) submission in the first quarter of 2025.
© 2024 Yahoo. All rights reserved.